Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
339,213,133
-
Share change
-
+334,782,349
-
Total reported value
-
$3,416,732,000
-
Price per share
-
$10.08
-
Number of holders
-
40
-
Value change
-
+$3,374,253,000
-
Number of buys
-
36
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q4 2021
As of 31 Dec 2021,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
339,213,133 shares.
The largest 10 holders included
QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, SC CHINA HOLDING Ltd, BlackRock Inc., Palantir Technologies Inc., FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and Founders Fund VI Management, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.